EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Impact of gestational diabetes mellitus and assisted reproductive technology on maternal and neonatal outcomes in twin pregnancies: A multicentre retrospective study in China

Li‐Yang Zhou, Xiao‐Bin Wu, Ya‐Qi Wang, Yu Hao, Ying‐Ling Yao, Rui‐Ling Liu, Zhou Xu, Kai Ye, Xiao‐Yan Chen, Yu‐Bin Ding

Diabetic Medicine · 2026-10-31

DOI: 10.1111/dme.70512 ↗
AbstractBibliografische Angaben

Abstract

Abstract Aims Twin pregnancies are inherently at high risk of maternal and neonatal complications. Assisted reproductive technology (ART) and gestational diabetes mellitus (GDM) are both common in this population, but it remains unclear whether their coexistence is associated with excess risk beyond their individual associations. Methods In this multicentre retrospective cohort of 4522 liveborn twin pregnancies across three hospitals in China, pregnancies were categorized according to mode of conception and GDM status. Generalized linear mixed models were used to estimate adjusted odds ratios (aORs) and 95% confidence intervals (CIs), with hospital included as a random effect. Multiplicative and additive interaction analyses were performed to assess whether the joint associations of ART and GDM with maternal and neonatal outcomes exceeded their individual associations. Results The overall prevalence of GDM was 22.2%, with 30.0% in ART‐conceived women and 14.0% in spontaneously conceived (SC) women. Compared to SC twin pregnancies without GDM, ART‐conceived twin pregnancies with GDM showed significantly increased risks of placental adhesion (aOR: 1.55; 95% CI: 1.03–2.33), caesarean section (aOR: 2.72; 95% CI: 1.21–6.15), preterm birth

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →